Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study

Medicine and Dentistry

• Asthma 90%
• Severe Asthma 90%
• Metabolite 72%
• Urinary System 45%
• Biological Marker 27%
• Icosanoid 27%
• Adult 27%
• Phenotype 18%
• Serositis 18%
• Respiratory Disease 18%
• Adolescent 18%
• Follow up 9%
• Measurement 9%
• Age 9%
• Prednisolone 9%
• Body Mass Index 9%
• Urine 9%
• Isoprostane Derivative 9%
• Nitric Oxide 9%
• Prostaglandin 9%
• Sputum 9%
• Corticosteroid Therapy 9%
• Peptidoleukotriene 9%
• Prostaglandin D2 9%
• Omalizumab 9%
• Association 9%
• Male 9%
• Marker 9%
• Lung 9%
• Childhood 9%
• Treatment of Asthma 9%
• Eosinophil 9%
• Blood 9%

Immunology and Microbiology

• Asthma 100%
• Metabolite 72%
• Phenotype 18%
• Inflammation 18%
• Age 9%
• Isoprostane Derivative 9%
• Eosinophil Granulocyte 9%
• Urine 9%
• Prostaglandin 9%
• Exhaled Nitric Oxide 9%
• Body Mass 9%
• Peptidoleukotriene 9%
• Sputum 9%
• Prostaglandin D2 9%
• Omalizumab 9%
• Association 9%
• Lung 9%
• Childhood 9%
• Prednisolone 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Asthma 90%
• Biological Marker 27%
• Icosanoid 27%
• Respiratory Tract Disease 18%
• Observational Study 18%
• Nitric Oxide 9%
• Prednisolone 9%
• Prostaglandin 9%
• Prostaglandin D2 9%
• Omalizumab 9%
• Isoprostane Derivative 9%
• Peptidoleukotriene 9%